can you take dpp4 and glp 1 together Mechanism of action for GIP, GLP-1 analogues inhibitors in dpp-4 inhibitors and glp-1 agonists

& Barker, F

Although MMF is a prodrug that is rapidly converted to the active metabolite, MPA, and Myfortic is an enteric-coated delayed-release formulation of MPA, both agents exert their immunosuppressive effects through selective inhibition of inosine monophosphate dehydrogenase (IMPDH), thereby suppressing T- and B-lymphocyte proliferation

When combined as part of a peptide treatment, CJC 1295 and Ipamorelin peptides have amplified effects, including slowing the aging process and maximizing growth

Users typically report reduction in age spots, melasma, post-inflammatory hyperpigmentation, and general skin dullness within 4-8 weeks of consistent supplementation